Vitamin D Deficiency Increases Severity of Paclitaxel-Induced Peripheral Neuropathy

PURPOSE: Approximately 25% of patients receiving weekly paclitaxel for breast cancer require treatment disruptions to avoid severe, irreversible peripheral neuropathy (PN). Vitamin insufficiencies are PN risk factors in many diseases, but their relevance to chemotherapy-induced PN is unknown. METHOD...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Breast Cancer Res Treat
Hlavní autoři: Jennaro, Theodore, Fang, Fang, Kidwell, Kelley M, Lavoie Smith, Ellen M., Vangipuram, Kiran, Burness, Monika L, Griggs, Jennifer J., Van Poznak, Catherine, Hayes, Daniel F., Henry, N. Lynn, Hertz, Daniel L.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2020
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7945004/
https://ncbi.nlm.nih.gov/pubmed/32166478
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-020-05584-8
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky